세계의 생체 임피던스 애널라이저 시장 예측(-2028년) : 유형(단주파수, 다주파수, 이중 주파수), 모달리티(유선, 무선), 용도(부위 측정, 전신 측정), 최종사용자(피트니스 클럽, 홈 사용자, 병원), 지역별

Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028

US $ 4,950 ￦ 6,786,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,117,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,174,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,711,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 생체 임피던스 애널라이저 시장 규모는 2023년 5억 6,400만 달러에서 예측 기간 중 10.4%의 CAGR로 추이하며, 2028년에는 9억 2,700만 달러 규모로 성장할 것으로 예측됩니다.

정부에 의한 건강한 라이프스타일의 추진, 피트니스 및 웰니스 센터의 증가, 영양사의 증가 등의 요인이 이 시장의 성장을 촉진하고 있습니다.

제품 유형별로 보면 다주파수 부문이 2022년에 최대 점유율을 보이며, 예측 기간 중 최대의 CAGR로 성장할 것으로 예측되고 있습니다. 데이터 분석을 강화하기 위한 웨어러블 디바이스나 이미징 기술 등 기타 기술과의 통합이 이 부문의 성장을 추진하고 있습니다.

최종사용자별로는 피트니스 클럽 & 웰니스 센터 부문이 예측 기간 중 최대의 CAGR을 나타낼 전망입니다. 짐이나 웰니스 센터의 증가, 건강과 피트니스에 대한 의식의 향상이 시장 성장을 촉진하는 주요 요인입니다.

지역별로는 북미 지역이 예측 기간 중 최대 점유율을 나타낼 전망입니다. 첨단 바이오 임피던스 애널라이저의 존재와 건강한 라이프스타일의 보급이 이 지역 시장의 성장을 지지하고 있습니다.

세계의 생체 임피던스 애널라이저 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허의 동향, 사례 연구, 관련 법규제, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 공급망 분석
• 밸류체인 분석
• 에코시스템 분석
• 규제 상황
• Porter's Five Forces 분석
• 특허 분석
• 무역 분석
• 기술 분석
• 가격 분석
• 고객의 사업에 영향을 미치는 동향/디스럽션

제6장 생체 임피던스 애널라이저 시장 : 제품별

• 다주파 생체 임피던스 애널라이저
• 단주파수 생체 임피던스 애널라이저
• 이중 주파수 생체 임피던스 애널라이저

제7장 생체 임피던스 애널라이저 시장 : 모달리티별

• 무선 생체 임피던스 애널라이저
• 유선 생체 임피던스 애널라이저

제8장 생체 임피던스 애널라이저 시장 : 사용 유형별

• 전문 등급
• 소비자 등급

제9장 생체 임피던스 애널라이저 시장 : 용도별

• 부위별 측정
• 전신 측정

제10장 생체 임피던스 애널라이저 시장 : 최종사용자별

• 피트니스 클럽·웰니스 센터
• 홈 사용자
• 병원·진료소
• 기타

제11장 생체 임피던스 애널라이저 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

제12장 경쟁 구도

• 개요
• 주요 기업 전략/유력 기업
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업/중소기업 기업 평가 매트릭스
• 경쟁 벤치마킹
• 경쟁 시나리오

제13장 기업 개요

• 주요 기업
  • OMRON CORPORATION
  • TANITA CORPORATION
  • INBODY CO., LTD.
  • RJL SYSTEMS, INC.
  • SECA GMBH & CO. KG
  • EVOLT 360
  • SELVAS HEALTHCARE(FORMERLY JAWON MEDICAL)
  • FOOK TIN TECHNOLOGIES LTD.
  • BODYSTAT LTD.
  • CHARDER ELECTRONIC CO., LTD.
  • MALTRON INTERNATIONAL
• 기타 기업
  • BIOTEKNA
  • BIODYNAMICS CORPORATION
  • AKERN
  • WITHINGS
  • XIAOMI
  • SINO-HERO(SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
  • LUMSAIL INDUSTRIAL INC.
  • GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
  • BIOPARHOM
  • MICROLIFE
  • SONKA MEDICAL TECHNOLOGY CO., LIMITED
  • NUMED S.A.R.L.
  • WUNDER SA.BI. SRL.
  • SHENZHEN YOLANDA TECHNOLOGY CO., LTD
  • BODIVIS(TONGFANG HEALTH TECHNOLOGY CO., LTD.)

제14장 부록

KSA

영문 목차

영문목차

The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number of nutritionists and dieticians. However, However, issues related high cost of professional-grade bioimpedance analyzers restrain the growth of the bioimpedance analyzers market.

"The multi-frequency bioimpedance analyzers segment accounted for the highest market share in the bioimpedance analyzers market, by product, during the forecast period."

Based on the product segment, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with other technologies, such as wearable devices or imaging techniques for enhancing data analysis.

"Fitness clubs & wellness centers accounted for the highest CAGR during the forecast period."

Based on end users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs & wellness centers, home users, and other end users. The fitness clubs & wellness centers segment dominated the bioimpedance analyzers market in 2022. This segment is expected to grow at the highest CAGR during the forecast period. The growing gyms and wellness centers and the rising awareness about health & fitness are the key factors driving market growth.

"The North America segment accounted for the highest market share in the bioimpedance analyzers market, by region, during the forecast period."

Based on the region, the global bioimpedance analyzers market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced bioimpedance analyzers and the increasing adoption of healthy lifestyles are supporting the growth of the bioimpedance analyzers market.

Breakdown of supply-side primary interviews by company type, designation, and region:

• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Asia- Pacific (34%), Europe (30%), and RoW (15%)

Prominent companies include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holdings Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Microlife (Switzerland), BioTekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), LUMSAIL Industrial Inc. (China), Microlife (Switzerland), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), BioparHom (France), Sonka Medical Technology Co., Limited (China), NUMED s.a.r.l. (Badaro), Wunder Sa.Bi. Srl. (Italy), Shenzhen Yolanda Technology Co., Ltd (China), and Bodivis (Tongfang Health Technology) (China).

Research Coverage

This research report categorizes the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioimpedance analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the bioimpedance analyzers market. Competitive analysis of upcoming startups in the bioimpedance analyzers market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioimpedance analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioimpedance analyzers market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioimpedance analyzers market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the bioimpedance analyzers market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the bioimpedance analyzers market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), Seca GmbH & Co. KG (Germany), among others in the bioimpedance analyzers market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • TABLE 1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
  • TABLE 2 KEY DATA FROM PRIMARY SOURCES
    • 2.1.2.1 Key industry insights
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
    • 2.2.1.1 Growth forecast
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
• FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2023 VS. 2028 (USD BILLION)
• FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION)
• FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION)
• FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
• FIGURE 14 BIOIMPEDANCE ANALYZERS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
  • FIGURE 15 INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS MARKET
• 4.2 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2022)
  • FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 2022
• 4.3 REGIONAL GROWTH OPPORTUNITIES IN BIOIMPEDANCE ANALYZERS MARKET
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 BIOIMPEDANCE ANALYZERS MARKET: REGIONAL MIX
  • FIGURE 18 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
• 4.5 BIOIMPEDANCE ANALYZERS MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 20 BIOIMPEDANCE ANALYZERS MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing prevalence of lifestyle diseases
    • 5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
    • 5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Presence of alternative methods
    • 5.2.2.2 High cost of analyzers
  • TABLE 3 BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emerging markets across Asia Pacific and Latin America
    • 5.2.3.2 Integration with wearable devices
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Inconsistency in accuracy of different bioimpedance analyzers
• 5.3 SUPPLY CHAIN ANALYSIS
  • FIGURE 21 DIRECT DISTRIBUTION-PREFERRED STRATEGY OF PROMINENT COMPANIES
• 5.4 VALUE CHAIN ANALYSIS
  • FIGURE 22 BIOIMPEDANCE ANALYZERS MARKET: VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 23 BIOIMPEDANCE ANALYZERS MARKET: ECOSYSTEM ANALYSIS
  • 5.5.1 ROLE IN ECOSYSTEM
  • FIGURE 24 BIOIMPEDANCE ANALYZERS MARKET ECOSYSTEM: KEY PLAYERS
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 NORTH AMERICA
    • 5.6.1.1 US
  • TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
    • 5.6.1.2 Canada
  • TABLE 5 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • 5.6.2 EUROPE
  • 5.6.3 ASIA PACIFIC
    • 5.6.3.1 Japan
  • TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    • 5.6.3.2 China
  • TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.6.3.3 India
  • TABLE 8 REGULATORY AUTHORITIES
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 BARGAINING POWER OF SUPPLIERS
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7.5 THREAT OF SUBSTITUTES
• 5.8 PATENT ANALYSIS
  • FIGURE 25 PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013-NOVEMBER 2022)
• 5.9 TRADE ANALYSIS
  • TABLE 9 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018-2022 (USD MILLION)
  • TABLE 10 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018-2022 (USD MILLION)
• 5.10 TECHNOLOGY ANALYSIS
• 5.11 PRICING ANALYSIS
  • TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
  • FIGURE 26 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS

6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 12 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
  • 6.2.1 ACCURACY AND PRECISION TO DRIVE MARKET
  • TABLE 13 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
  • TABLE 14 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
  • 6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE MARKET
  • TABLE 15 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
  • TABLE 16 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
  • 6.4.1 SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH
  • TABLE 17 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
  • TABLE 18 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY

• 7.1 INTRODUCTION
  • TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
• 7.2 WIRELESS BIOIMPEDANCE ANALYZERS
  • 7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE
  • TABLE 20 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.3 WIRED BIOIMPEDANCE ANALYZERS
  • 7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE DEMAND
  • TABLE 21 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE

• 8.1 INTRODUCTION
  • TABLE 22 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021-2028 (USD MILLION)
• 8.2 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS
  • 8.2.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET
  • TABLE 23 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.3 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS
  • 8.3.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET
  • TABLE 24 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)

9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION

• 9.1 INTRODUCTION
  • TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 9.2 SEGMENTAL BODY MEASUREMENT
  • 9.2.1 RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION
  • TABLE 26 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021-2028 (USD MILLION)
• 9.3 WHOLE-BODY MEASUREMENT
  • 9.3.1 GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET
  • TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021-2028 (USD MILLION)

10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER

• 10.1 INTRODUCTION
  • TABLE 28 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.2 FITNESS CLUBS & WELLNESS CENTERS
  • 10.2.1 FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET
  • FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012-2022
  • TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021-2028 (USD MILLION)
• 10.3 HOME USERS
  • 10.3.1 AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION
  • TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2021-2028 (USD MILLION)
• 10.4 HOSPITALS & CLINICS
  • 10.4.1 NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION
  • TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021-2028 (USD MILLION)
• 10.5 OTHER END USERS
  • TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION

• 11.1 INTRODUCTION
  • TABLE 33 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 11.2 NORTH AMERICA
  • FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
  • TABLE 34 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.1 RECESSION IMPACT
  • 11.2.2 US
    • 11.2.2.1 Rising obesity rate and interest in health clubs & fitness centers to drive market
  • TABLE 40 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 41 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 42 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 43 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.3 CANADA
    • 11.2.3.1 High prevalence of obesity in Canada to support market growth
  • TABLE 44 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 45 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 46 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 47 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 11.3 EUROPE
  • TABLE 48 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 49 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 50 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 51 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021-2028 (USD MILLION)
  • TABLE 52 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 53 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.1 RECESSION IMPACT
  • 11.3.2 GERMANY
    • 11.3.2.1 Germany to hold largest market share in Europe
  • TABLE 54 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 55 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 56 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 57 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.3 UK
    • 11.3.3.1 Rising incidence of kidney disorders to drive market
  • TABLE 58 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 59 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 60 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 61 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.4 FRANCE
    • 11.3.4.1 Increasing obese population and rising prevalence of metabolic disorders to drive market
  • TABLE 62 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 63 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 64 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 65 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.5 REST OF EUROPE
  • TABLE 66 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 67 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 68 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 69 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 11.4 ASIA PACIFIC
  • 11.4.1 RECESSION IMPACT
  • FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
  • TABLE 70 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021-2028 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.2 JAPAN
    • 11.4.2.1 Government initiatives to drive market
  • TABLE 76 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 77 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 78 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 79 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.3 CHINA
    • 11.4.3.1 China to register highest CAGR in APAC market
  • TABLE 80 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 81 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 82 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 83 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 High prevalence of obesity to drive market
  • TABLE 84 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 85 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 86 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 87 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.5 PHILIPPINES
    • 11.4.5.1 Favorable government initiatives to support market growth
  • TABLE 88 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 89 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 90 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 91 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.6 TAIWAN
    • 11.4.6.1 Increasing incidence of lifestyle diseases to drive market
  • TABLE 92 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 93 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 94 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 95 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.7 REST OF ASIA PACIFIC
  • TABLE 96 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 97 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 98 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 99 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 11.5 REST OF THE WORLD
  • 11.5.1 RECESSION IMPACT
  • TABLE 100 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 101 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021-2028 (USD MILLION)
  • TABLE 102 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 103 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
• 12.3 MARKET SHARE ANALYSIS
  • TABLE 105 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
• 12.4 COMPANY EVALUATION MATRIX (2022)
  • 12.4.1 STARS
  • 12.4.2 EMERGING LEADERS
  • 12.4.3 PERVASIVE PLAYERS
  • 12.4.4 PARTICIPANTS
  • FIGURE 30 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022
• 12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
  • 12.5.1 PROGRESSIVE COMPANIES
  • 12.5.2 STARTING BLOCKS
  • 12.5.3 RESPONSIVE COMPANIES
  • 12.5.4 DYNAMIC COMPANIES
  • FIGURE 31 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
• 12.6 COMPETITIVE BENCHMARKING
  • TABLE 106 BIOIMPEDANCE ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • TABLE 107 PRODUCT FOOTPRINT ANALYSIS
  • TABLE 108 REGIONAL FOOTPRINT ANALYSIS
  • TABLE 109 BIOIMPEDANCE ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES
• 12.7 COMPETITIVE SCENARIO
  • 12.7.1 PRODUCT LAUNCHES
  • TABLE 110 PRODUCT LAUNCHES, 2020-2023
  • 12.7.2 DEALS
  • TABLE 111 DEALS, 2020-2023
  • 12.7.3 OTHER DEVELOPMENTS
  • TABLE 112 OTHER DEVELOPMENTS, 2020-2023

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 13.1.1 OMRON CORPORATION
• TABLE 113 OMRON CORPORATION: BUSINESS OVERVIEW
• FIGURE 32 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
• 13.1.2 TANITA CORPORATION
• TABLE 114 TANITA CORPORATION: BUSINESS OVERVIEW
• 13.1.3 INBODY CO., LTD.
• TABLE 115 INBODY CO., LTD.: BUSINESS OVERVIEW
• TABLE 116 INBODY CO., LTD.: DEALS
• TABLE 117 INBODY CO., LTD.: OTHER DEVELOPMENTS
• 13.1.4 RJL SYSTEMS, INC.
• TABLE 118 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
• 13.1.5 SECA GMBH & CO. KG
• TABLE 119 SECA GMBH & CO. KG: BUSINESS OVERVIEW
• 13.1.6 EVOLT 360
• TABLE 120 EVOLT 360: BUSINESS OVERVIEW
• 13.1.7 SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL)
• TABLE 121 SELVAS HEALTHCARE: BUSINESS OVERVIEW
• 13.1.8 FOOK TIN TECHNOLOGIES LTD.
• TABLE 122 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
• 13.1.9 BODYSTAT LTD.
• TABLE 123 BODYSTAT LTD.: BUSINESS OVERVIEW
• TABLE 124 BODYSTAT LTD.: PRODUCT LAUNCHES
• 13.1.10 CHARDER ELECTRONIC CO., LTD.
• TABLE 125 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
• 13.1.11 MALTRON INTERNATIONAL
• TABLE 126 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 13.2 OTHER PLAYERS
  • 13.2.1 BIOTEKNA
  • 13.2.2 BIODYNAMICS CORPORATION
  • 13.2.3 AKERN
  • 13.2.4 WITHINGS
  • 13.2.5 XIAOMI
  • 13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
  • 13.2.7 LUMSAIL INDUSTRIAL INC.
  • 13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
  • 13.2.9 BIOPARHOM
  • 13.2.10 MICROLIFE
  • 13.2.11 SONKA MEDICAL TECHNOLOGY CO., LIMITED
  • 13.2.12 NUMED S.A.R.L.
  • 13.2.13 WUNDER SA.BI. SRL.
  • 13.2.14 SHENZHEN YOLANDA TECHNOLOGY CO., LTD
  • 13.2.15 BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.)

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

관련자료